Investors

Insider Transactions

Date Sorted Descending Name Title Type Shares Traded Price Range
Dec 16, 2014 yancopoulos george Officer Option Execute 3,264 30.63
Dec 15, 2014 mccorkle douglas s Officer Automatic Sell 1,668 410.16 - 417.34
Dec 15, 2014 mccorkle douglas s Officer Option Execute 1,668 30.63
Nov 25, 2014 poon christine a Director Buy 400 410.00
Nov 24, 2014 brown michael s Director Disposition (Non Open Market) 2,000 n/a
Nov 24, 2014 gilman alfred g Director Sell 40,000 405.65 - 411.06
Nov 24, 2014 gilman alfred g Director Option Execute 40,000 24.41 - 57.11
Nov 24, 2014 stahl neil Officer Sell 2,200 409.71 - 410.10
Nov 21, 2014 stahl neil Officer Sell 3,107 415.16
Nov 18, 2014 stahl neil Officer Disposition (Non Open Market) 11,700 0.00 - 406.93
Nov 18, 2014 stahl neil Officer Option Execute 16,757 115.29
Nov 18, 2014 terifay robert j Officer Automatic Sell 22,362 400.45 - 408.62
Nov 17, 2014 goldberg murray a Officer Disposition (Non Open Market) 1,930 n/a
Nov 17, 2014 terifay robert j Officer Automatic Sell 26,388 401.75
Nov 17, 2014 terifay robert j Officer Option Execute 48,750 21.25
Nov 17, 2014 vagelos p roy Officer Disposition (Non Open Market) 24,900 n/a
Nov 14, 2014 yancopoulos george Officer Disposition (Non Open Market) 2,313 n/a
Nov 13, 2014 van plew daniel p Officer Sell 8,575 399.21 - 399.95
Nov 12, 2014 goldstein joseph l Director Sell 5,000 398.31
Nov 12, 2014 goldstein joseph l Director Option Execute 5,000 177.82
Showing 41-60 of 920 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)